CA1138776A - Methode de preparation de d-penicillamine et preparation qui en renferme - Google Patents

Methode de preparation de d-penicillamine et preparation qui en renferme

Info

Publication number
CA1138776A
CA1138776A CA000167082A CA167082A CA1138776A CA 1138776 A CA1138776 A CA 1138776A CA 000167082 A CA000167082 A CA 000167082A CA 167082 A CA167082 A CA 167082A CA 1138776 A CA1138776 A CA 1138776A
Authority
CA
Canada
Prior art keywords
penicillamine
composition
acid
synthetic
cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000167082A
Other languages
English (en)
Other versions
CA167082S (en
Inventor
Friedrich Asinger
Heribert Offermanns
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Deutsche Gold und Silber Scheideanstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsche Gold und Silber Scheideanstalt filed Critical Deutsche Gold und Silber Scheideanstalt
Application granted granted Critical
Publication of CA1138776A publication Critical patent/CA1138776A/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000167082A 1972-03-25 1973-03-26 Methode de preparation de d-penicillamine et preparation qui en renferme Expired CA1138776A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2214814A DE2214814A1 (de) 1972-03-25 1972-03-25 Zubereitungen, die vollsynthetisch hergestelltes d-penicillamin enthalten
DEP2214814.7 1972-03-25

Publications (1)

Publication Number Publication Date
CA1138776A true CA1138776A (fr) 1983-01-04

Family

ID=5840274

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000167082A Expired CA1138776A (fr) 1972-03-25 1973-03-26 Methode de preparation de d-penicillamine et preparation qui en renferme

Country Status (6)

Country Link
BE (1) BE797282A (fr)
CA (1) CA1138776A (fr)
DE (1) DE2214814A1 (fr)
HU (1) HU170551B (fr)
SE (1) SE394175B (fr)
ZA (1) ZA731909B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070134277A1 (en) * 2005-12-09 2007-06-14 Children's Medical Center Corporation Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB585413A (en) * 1944-06-19 1947-02-06 Wellcome Found Improved method for the resolution of penicillamine
CH540234A (de) * 1968-09-06 1973-08-15 Degussa Verfahren zur Herstellung von Penicillamin
US3793462A (en) * 1970-10-16 1974-02-19 M Kludas Treatment of scleroses

Also Published As

Publication number Publication date
ZA731909B (en) 1973-12-19
BE797282A (fr) 1973-09-24
DE2214814A1 (de) 1973-09-27
SE394175B (sv) 1977-06-13
HU170551B (fr) 1977-07-28

Similar Documents

Publication Publication Date Title
EP0830863B1 (fr) Médicaments améliorateurs de l'irrigation sanguine gastrointestinale
EP0236872B1 (fr) Dérivés hydroxylamine, leur préparation et emploi comme médicaments
EP0089637B1 (fr) Dérivés d'amino acides bicycliques, procédé pour leur préparation, agents les contenant et leur utilisation, ainsi que des amino acides bicycliques comme produits intermédiaires et procédé pour leur préparation
EP0608759B1 (fr) Dérivés de pipérazines
JPS604815B2 (ja) プロリン誘導体
DE3508251A1 (de) Dipeptide
CZ286621B6 (cs) Tromethaminová sůl (+)-(S)-2-(3-benzoylfenyl)propionové kyseliny, způsob její výroby a farmaceutický prostředek s jejím obsahem
DE69832268T2 (de) Peptidyl2-amino-1hydroxyalkansulfonsäuren als zysteinprotease-inhibitoren
US4426391A (en) [(Alkoxycarbonyl)oxy]alkyl esters of methyldopa
DE69738373T2 (de) Prenyl-transferase inhibitoren
DE4443390A1 (de) Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten
DE69628360T2 (de) Azepinonverbindungen zur Anwendung bei der Hemmung von ACE und NEP
DE2332837A1 (de) Amine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0243645B1 (fr) Composés à activité nootrope, les agents les contenant et leur emploi pour le traitement prophylactique des dysfonctions cognitives
EP0110224A2 (fr) Composés benzoylthio, leur préparation et emploi comme médicaments
DE1795022C3 (de) Lysergsäurederivate
JPS6251A (ja) シス,エンド−2−アザビシクロ〔3.3.0〕オクタン−3−カルボン酸誘導体およびその製法
DE69921314T2 (de) INHIBITORISCHE ESTER FÜR sPLA 2
CA1138776A (fr) Methode de preparation de d-penicillamine et preparation qui en renferme
DE69826881T2 (de) Neue indolcarboxamide, pharmazeutische zusammensetzungen und methoden zur hemmung von calpain
DE60010711T2 (de) Amido-spiropiperidine promovieren die freisetzung von wachstumshormonen
DE69838686T2 (de) Tripeptidylpeptidaseinhibitoren
US4587250A (en) Thiazaspirane derivatives, process for their preparation, and medicaments
DE69829654T2 (de) Verfahren zur herstellung von rhizoferrin
JPS61502468A (ja) N−置換ブチルアミド誘導体

Legal Events

Date Code Title Description
MKEX Expiry